November 5, 2026 · Sheraton Times SquareNew York City
In conjunction with OSN New York & Retina
The Empire Forum
Retina Pipeline and Markets at OSN New York & Retina
Innovation. Insight. Investment. Shaping the Future of Retinal Therapeutics.
The Forum
Direct dialogue between clinicians, industry, and investors.
A one-day executive forum bringing together retina specialists, biotechnology innovators, pharmaceutical leaders, and healthcare investors to discuss the therapies and technologies that will shape retinal care over the next decade.
Unlike traditional scientific congresses, The Empire Forum is built for direct interaction among clinical investigators, industry decision-makers, investors, and key opinion leaders. The focus: late-stage clinical development, emerging science, commercialization pathways, investment trends, and what upcoming therapies mean in practice.
Expected audience
0+
Attendees
- Retina specialists
- Pharmaceutical & biotech executives
- Medical Affairs leaders
- Investors
- Business Development executives
Empire Forum begins in
November 5, 2026 · 12:00 PM to 8:00 PM · Sheraton Times Square, New York City
Attending OSN New York & Retina?
Arrive a day early. Walk downstairs.
The Empire Forum takes place in the same hotel as OSN New York & Retina, the day before it begins, and starts at noon on purpose. Fly in that morning, or drive in from New York, Boston, Philadelphia, or Washington, and be seated when the first session opens.
Registration
Advance Registration
$100
Register in advance and secure your place at the Empire Forum. Advance registration ends September 30, 2026.
On-Site Registration
$200
On-site registration will be available subject to space availability. Advance registration is strongly encouraged.
Where Science, Industry, and Capital Meet
Science
Leading retinal disease investigators and clinicians
Industry
Emerging and established pharmaceutical and biotechnology companies
Capital
Institutional investors, venture firms, and strategic partners
Three communities that rarely convene in one room, for one focused day.
Co-Chairs & Moderators
Chaired by two of the leading voices in retina.
Rishi P. Singh, MD, FASRS
Chair, Department of Ophthalmology
Mass Eye and Ear, Mass General Brigham · Harvard Medical School
“Retina is entering an extraordinary period of scientific progress. The Empire Forum will bring clinicians, innovators, and investors together to examine which emerging therapies have the greatest potential to meaningfully improve patient care.”
“By creating a setting for candid discussion across medicine, industry, and capital, we can look beyond promising data and address the practical questions that determine whether innovation ultimately reaches patients.”
David Eichenbaum, MD, FASRS
Partner, Director of Research
Retina Vitreous Associates of Florida · Collaborative Associate Professor, Morsani College of Medicine - University of South Florida
“The retinal pipeline has never been more diverse, spanning sustained-delivery platforms, novel biologics, and genetic and cellular therapies. This forum gives us an opportunity to evaluate that innovation through both a scientific and real-world clinical lens.”
“Meaningful progress requires more than a successful clinical trial. It requires a clear understanding of patient needs, treatment burden, commercialization, and adoption, and those are precisely the conversations The Empire Forum is designed to foster.”
Nationally recognized retina opinion leaders will participate throughout the program as moderators and commentators, providing scientific and treatment perspective and engaging presenters in strategic discussion.
Scientific Program
Five sections. The full retinal pipeline.
I
Geographic Atrophy
Complement inhibition · Neuroprotection · Mitochondrial therapies · Novel biologic and delivery approaches · Emerging Phase 2 and Phase 3 programs
II
Wet AMD
Sustained delivery technologies · Gene therapies · VEGF pathway innovations · Novel mechanisms of action
III
Diabetic Macular Edema
Extended-duration therapies · Combination approaches · Novel biologics · Future treatment paradigms
IV
Rare and Inherited Retinal Diseases
Gene replacement · Gene editing · Cell therapies · Commercialization challenges and opportunities
V
Investment Forum: Financing the Future of Retina Innovation
Institutional investment firms, healthcare-focused venture funds, corporate venture organizations, equity research analysts, and strategic investors on capital formation trends, funding strategies, M&A outlook, partnering opportunities, and the pipeline and commercial outlook
Format & Agenda
One focused afternoon, built to end in conversation.
The program starts at noon on purpose: OSN New York & Retina attendees can arrive that morning and be seated for the first session, in the same hotel.
12:00 PM to 7:00 PM
Scientific presentations, panel discussions, and exhibit forum
- 7-minute podium presentations with 3-minute Q&A
- Moderated panel discussions
- KOL commentary sessions
- Investor presentations
7:00 PM to 8:00 PM
Networking cocktail reception
Who attends
Empire Forum Sponsors
The Empire Forum is supported by leading organizations advancing retinal therapeutics.
Sponsorship Opportunities
A direct line to the people who move retina forward.
Sponsoring organizations gain a highly efficient platform to showcase innovation, communicate clinical and strategic developments, and engage directly with influential retina specialists and investment leaders.
Why companies sponsor Empire Forum
- Direct access to retina specialists and retina thought leaders
- Visibility among pharmaceutical and biotechnology executives
- Exposure to institutional investors, venture capital groups, and strategic partners
- A platform to communicate pipeline progress and corporate strategy
- Opportunities to generate awareness, partnerships, and investment interest
- Participation in focused discussion on the future retinal therapeutic landscape
- Meet retina opinion leaders in one setting
- Build relationships with investors and strategic partners
- Increase visibility ahead of OSN New York & Retina
- Receive direct feedback on emerging science
- Position their organization alongside leaders in retinal innovation
2026 Empire Forum is fully committed.
Please contact dansalomone@bpmedsol.com regarding Empire Forum 2027.
dansalomone@bpmedsol.comPlatinum Sponsorship
Premier Industry Leadership Partner
$25,000
- Podium presentation: 7 minutes plus Q&A
- KOL-led panel discussion: 30 minutes for additional questions and context
- 5 attendee badges (additional badges available at $200 each)
- Premium recognition in meeting materials
- Exhibit booth in meeting room
- Company recognition from the podium
- Video recording of proceedings
- Complete attendee list
- Sponsor logo on meeting website and signage
- Priority positioning among sponsors
Gold Sponsorship
Strategic Innovation Partner
$15,000
- KOL-led panel discussion: 30 minutes for additional questions and context
- Exhibit booth in meeting room
- Recognition in meeting materials
- 3 attendee badges
- Video recording of proceedings
- Complete attendee list
- Sponsor logo on meeting signage
Silver Sponsorship
Supporting Industry Partner
$10,000
- Exhibit booth in meeting room
- 2 attendee badges
- Recognition in meeting materials
- Sponsor logo displayed throughout meeting
- Complete attendee list
Other Exclusive Sponsorship Opportunities
Cocktail Reception Sponsor$5,000
Exclusive recognition during the networking reception, branded signage, recognition from the podium, logo placement throughout the reception area
Breaks Sponsor$5,000
Recognition during refreshment breaks, signage at break stations, logo inclusion in meeting materials
Exhibit Booth Only (if space permits)$5,000
Exhibit table, company signage, access to networking activities, inclusion in attendee materials
Meeting Handout Sponsor$2,500
Exclusive branding on printed meeting materials, recognition throughout the meeting
Badge Lanyard Sponsor$1,500
Exclusive logo placement on attendee lanyards, high-visibility branding throughout the event
Stage Logo Sponsor$1,500
Logo placement in a high-visibility position on the presentation stage
Sponsorship
The 2026 meeting is fully committed.
Every sponsorship for the 2026 meeting has been taken. Companies interested in presenting emerging science, discussing pipeline strategy, engaging retina leaders, and building relationships with investors are encouraged to get in touch about next year.
2026 Empire Forum is fully committed.
Please contact dansalomone@bpmedsol.com regarding Empire Forum 2027.
dansalomone@bpmedsol.comDirect contact
Daniel Salomone
CEO & Founder, BioPharma Medical Solutions